X4 Pharmaceuticals (XFOR) Other Non-Current Liabilities (2017 - 2026)
X4 Pharmaceuticals' Other Non-Current Liabilities was $523,000 in Q2 2026, down 2.2% from $535,000 a year earlier and down 41.7% from the prior quarter.
X4 Pharmaceuticals (XFOR) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Liabilities at X4 Pharmaceuticals came in at $977,000, down 92.9% from FY2024.
- Other Non-Current Liabilities has now declined for three consecutive years, though with a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
- In earlier years, Other Non-Current Liabilities was $13.76 million in FY2024 (-12.3%), $15.68 million in FY2023 (-32.2%), $23.13 million in FY2022 and $826,000 in FY2021 (+78.8%).
- The Q2 2026 figure marks the lowest quarterly Other Non-Current Liabilities since Q3 2022.
- Compared with a year earlier, Other Non-Current Liabilities has declined for nine straight quarters, with an average decline of 62.8% over the last eight quarters.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q4 2021 (growth of 78.8%); the worst was Q2 2025 (a decline of 94.2%).
- Per Business Quant data, XFOR's Other Non-Current Liabilities in the three quarters before Q2 2026 was $897,000 (Q1 2026), $977,000 (Q4 2025) and $959,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | X4 Pharmaceuticals | 408.09 Mn | -290.59 Mn | 7.19 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 892,000.00 |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 818,000.00 |
| Mar 31, 2025 | 3.49 Mn |
| Dec 31, 2024 | 14.60 Mn |
| Sep 30, 2024 | 12.31 Mn |
| Jun 30, 2024 | 10.20 Mn |
| Mar 31, 2024 | 30.46 Mn |
| Dec 31, 2023 | 16.12 Mn |
| Sep 30, 2023 | 23.10 Mn |
| Jun 30, 2023 | 48.65 Mn |
| Mar 31, 2023 | 18.04 Mn |
| Dec 31, 2022 | 23.30 Mn |
| Sep 30, 2022 | 312,000.00 |
| Jun 30, 2022 | 314,000.00 |
| Mar 31, 2022 | 650,000.00 |
| Dec 31, 2021 | 826,000.00 |
| Sep 30, 2021 | 496,000.00 |
X4 Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=XFOR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();